UnitedHealth Group Incorporated (NYSE:UNH) had its target price hoisted by Argus from $215.00 to $230.00 in a report published on Thursday morning. The brokerage currently has a buy rating on the healthcare conglomerate’s stock.
Several other equities research analysts also recently commented on the stock. Cantor Fitzgerald reiterated an overweight rating and set a $208.00 price objective on shares of UnitedHealth Group in a research note on Friday, July 21st. ValuEngine upgraded shares of UnitedHealth Group from a hold rating to a buy rating in a research note on Friday, September 1st. Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Monday, July 31st. Oppenheimer Holdings, Inc. reiterated an outperform rating and set a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, BidaskClub downgraded shares of UnitedHealth Group from a strong-buy rating to a buy rating in a research note on Wednesday, July 19th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group currently has a consensus rating of Buy and an average price target of $215.27.
UnitedHealth Group (NYSE:UNH) traded up 2.09% during trading on Thursday, hitting $207.49. The stock had a trading volume of 5,138,814 shares. The stock has a market cap of $205.21 billion, a price-to-earnings ratio of 23.56 and a beta of 0.63. UnitedHealth Group has a 12 month low of $133.03 and a 12 month high of $208.21. The firm has a 50 day moving average of $197.17 and a 200-day moving average of $185.63.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the firm posted $2.17 earnings per share. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group will post $9.96 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Given New $230.00 Price Target at Argus” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://stocknewstimes.com/2017/10/20/unitedhealth-group-incorporated-unh-given-new-230-00-price-target-at-argus.html.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 77,149 shares of company stock valued at $15,182,242. 0.89% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Rockefeller Financial Services Inc. grew its stake in UnitedHealth Group by 6.0% during the 3rd quarter. Rockefeller Financial Services Inc. now owns 20,106 shares of the healthcare conglomerate’s stock valued at $3,938,000 after acquiring an additional 1,142 shares in the last quarter. Summit X LLC grew its stake in UnitedHealth Group by 45.1% during the 3rd quarter. Summit X LLC now owns 5,553 shares of the healthcare conglomerate’s stock valued at $1,095,000 after acquiring an additional 1,727 shares in the last quarter. Assenagon Asset Management S.A. purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $1,741,000. Asset Dedication LLC grew its stake in UnitedHealth Group by 5.6% during the 3rd quarter. Asset Dedication LLC now owns 8,528 shares of the healthcare conglomerate’s stock valued at $1,678,000 after acquiring an additional 454 shares in the last quarter. Finally, Balasa Dinverno & Foltz LLC grew its stake in UnitedHealth Group by 6.0% during the 3rd quarter. Balasa Dinverno & Foltz LLC now owns 9,324 shares of the healthcare conglomerate’s stock valued at $1,826,000 after acquiring an additional 531 shares in the last quarter. 86.11% of the stock is owned by institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.